Citation: Mm. Dimachkie et al., PHENYTOIN-INDUCED DERMATOMYOSITIS - CASE-REPORT AND LITERATURE-REVIEW, Journal of child neurology, 13(11), 1998, pp. 577-580
Authors:
AUSTIN SA
VRIESENDORP FJ
THANDROYEN FT
HECHT JT
JONES OT
JOHNS DR
Citation: Sa. Austin et al., EXPANDING THE PHENOTYPE OF THE 8344-TRANSFER RNA(LYSINE) MITOCHONDRIAL-DNA MUTATION, Neurology, 51(5), 1998, pp. 1447-1450
Authors:
VRIESENDORP FJ
FLYNN RE
MALONE MR
PAPPOLLA MA
Citation: Fj. Vriesendorp et al., SYSTEMIC COMPLEMENT DEPLETION REDUCES INFLAMMATION AND DEMYELINATION IN ADOPTIVE TRANSFER EXPERIMENTAL ALLERGIC NEURITIS, Acta Neuropathologica, 95(3), 1998, pp. 297-301
Citation: Fj. Vriesendorp, INSIGHTS INTO CAMPYLOBACTER JEJUNI-INDUCED GUILLAIN-BARRE-SYNDROME FROM THE LEWIS RAT MODEL OF EXPERIMENTAL ALLERGIC NEURITIS, The Journal of infectious diseases, 176, 1997, pp. 164-168
Authors:
VRIESENDORP FJ
FLYNN RE
KHAN M
PAPPOLLA MA
BROD SA
Citation: Fj. Vriesendorp et al., ORAL-ADMINISTRATION OF TYPE-I INTERFERON MODULATES THE COURSE OF EXPERIMENTAL ALLERGIC NEURITIS, Autoimmunity, 24(3), 1996, pp. 157-165
Authors:
FLYNN R
VRIESENDORP FJ
KHAN M
PAPPOLLA M
BROD S
Citation: R. Flynn et al., ORAL-ADMINISTRATION OF TYPE-I INTERFERON MODULATES THE COURSE OF EXPERIMENTAL ALLERGIC NEURITIS, Neurology, 46(2), 1996, pp. 4001-4001
Citation: Fj. Vriesendorp et al., ELECTROPHYSIOLOGICAL STUDIES IN GUILLAIN-BARRE-SYNDROME - CORRELATIONWITH ANTIBODIES TO GM1, GD1B AND CAMPYLOBACTER-JEJUNI, Journal of neurology, 242(7), 1995, pp. 460-465
Authors:
VRIESENDORP FJ
FLYNN RE
PAPPOLLA MA
KOSKI CL
Citation: Fj. Vriesendorp et al., COMPLEMENT DEPLETION AFFECTS DEMYELINATION AND INFLAMMATION IN EXPERIMENTAL ALLERGIC NEURITIS, Journal of neuroimmunology, 58(2), 1995, pp. 157-165
Authors:
JOHNSON KP
BROOKS BR
COHEN JA
FORD CC
GOLDSTEIN J
LISAK RP
MYERS LW
PANITCH HS
ROSE JW
SCHIFFER RB
VOLLMER T
WEINER LP
WOLINSKY JS
BIRD SJ
CONSTANTINESCU C
KOLSON DL
GONZALEZSCARANO F
BRENNAN D
PFOHL D
MANDLER RN
ROSENBERG GA
JEFFREY C
BARGER GR
GANDHI B
MOORE PM
ROGERS LR
LISAK D
SMITH L
ELLISON GW
BAUMHEFNER RW
CRAIG SL
JALBUT SS
KATZ E
CONWAY KL
BURNS JB
SHIBA C
GIANG DW
PETRIE MD
GUARNACCIA JB
ANDERSON S
MCKEON A
MCCARTHY M
THOMAS AB
VRIESENDORP FJ
AUSTIN SG
LINDSEY JW
DIMACHKIE M
CERRETA E
KACHUCK N
MCCARTHY KA
FLEMING J
PARNELL JH
TAMULEVICH J
WEASLER C
KADOSH S
HALT H
STARK Y
PINCHASI I
SPILLER N
VANDENNOORT S
MILLER A
MELLITS D
HOPKINS J
REINGOLD S
GOMOLIN IH
Citation: Kp. Johnson et al., COPOLYMER-1 REDUCES RELAPSE RATE AND IMPROVES DISABILITY IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS - RESULTS OF A PHASE-III MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, Neurology, 45(7), 1995, pp. 1268-1276
Authors:
VRIESENDORP FJ
MISHU B
BLASER MJ
KOSKI CL
Citation: Fj. Vriesendorp et al., SERUM ANTIBODIES TO GM1, GD1B, PERIPHERAL-NERVE MYELIN, AND CAMPYLOBACTER-JEJUNI IN PATIENTS WITH GUILLAIN-BARRE-SYNDROME AND CONTROLS - CORRELATION AND PROGNOSIS, Annals of neurology, 34(2), 1993, pp. 130-135
Authors:
VRIESENDORP FJ
DMYTRENKO GS
DIETRICH T
KOSKI CL
Citation: Fj. Vriesendorp et al., ANTI-PERIPHERAL NERVE MYELIN ANTIBODIES AND TERMINAL ACTIVATION PRODUCTS OF COMPLEMENT IN SERUM OF PATIENTS WITH ACUTE BRACHIAL-PLEXUS NEUROPATHY, Archives of neurology, 50(12), 1993, pp. 1301-1303